Group 2B is a classification used by the International Agency for Research on Cancer (IARC) to identify agents that are possibly carcinogenic to humans. This category indicates that there is limited evidence of carcinogenicity in humans and less than sufficient evidence in experimental animals. It serves as a signal to scientists and the public that more research is needed to fully understand the potential risks.
